#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell type acute leukaemia T-cell lymphoma Phaeochromocytoma Rhabdoid tumour Osteosarcoma Castleman's disease Congenital absence of bile ducts Still's disease Complex regional pain syndrome Cystic fibrosis gastrointestinal disease Leukoencephalopathy Measles Hodgkin's disease Breast angiosarcoma Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Life with Disease Systemic sclerosis pulmonary – Basic Information IgA nephropathy – Basic Information MELAS syndrome – Basic Information Gastrointestinal stromal tumour – Life with Disease Hereditary optic atrophy – Trials in Disease Lymphangiosarcoma – Basic Information Epidermolysis bullosa – Basic Information Osteosarcoma recurrent Kearns-Sayre syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cyanocobalamin Brexpiprazole Etravirine Pp1493 Pilocarpine Nitrate Levosimendan Diclofenac Diethylamine ANUMIGILIMAB Elraglusib Barzolvolimab Argatroban Monohydrate Acetylcysteine Ceritinib Empagliflozin LIPASE BENZYLPENICILLIN POTASSIUM RLY-2608 Phleum Pratense Vx-670 S230815-2 More therapies…

    Learn about Your Condition

    Graft versus host disease Asymptomatic HIV infection Respiratory distress Infective uveitis Systemic infection Peritoneal neoplasm Acute on chronic liver failure Porphyria non-acute Cystic fibrosis lung Thyroidectomy Tinnitus Intervertebral disc protrusion Tendon disorder Propionic acidaemia Mantle cell lymphoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Hungary +6

  • A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Vh4524184
    Belgium France Germany Italy Poland Portugal +1

  • A Study of Sonlicromanol for Reducing Fatigue in Patients with Long COVID

    Recruiting

    2 1
    Investigated Drugs:
    • SONLICROMANOL HYDROCHLORIDE
    The Netherlands

  • A study testing tulmimetostat with darolutamide or abiraterone in patients with metastatic hormone-sensitive prostate cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Tulmimetostat
    • Abiraterone
    • Darolutamide
    France Germany Hungary Italy Spain

  • A study testing Wharton’s jelly-derived mesenchymal stem cells with spinal cord stimulation for adults with chronic spinal cord injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Spinal cord injury
    Investigated Drugs:
    • ALLOGENEIC VIABLE WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS, EX-VIVO EXPANDED
    Spain

  • A Study of Tulmimetostat and Luxdegalutamide Compared to Standard Treatment in Men with Advanced Prostate Cancer That No Longer Responds to Hormone Therapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Tulmimetostat
    • LUXDEGALUTAMIDE
    • Cabazitaxel
    Denmark France Germany Italy Poland Spain
Previous Page
1 … 91 92 93 94 95 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!